Unlock the Value of your Assets !
Strategies, tactics, insights and opportunities.

 

“Several studies show that similar to FMCG companies, pharma and biotech companies are facing an increasing number of difficulties when launching or selling their products in the expanding Europe. A high degree of diversity and increasing competition make it difficult to enter European markets without carefully benchmarking success stories from these numerous markets.”

 We assure in and out product licensing, pharma/biotech product & development process sales, Marketing and Sales support (including export development).

 

    Press Release:
RidePharm and 4Vision form Alliance to expand their consulting excellence in the Pharma and Biotech industry.
Geneva, Switzerland; Westerbork, The Netherlands, April 21, 2008 – RidePharm and 4Vision today announced their alliance for the further development of their customer and product portfolio. The companies will work together to increase their opportunities across Europe and beyond. In this alliance they will combine their capacities and present and future assignments. Particular emphasis will be given to the all aspects in the field of business development and advisory functions for Biotech and Pharma companies. RidePharm and 4Vision current portfolios include different pre-clinical candidates available for licensing, marketed products (including medical devices) for European Markets, several technologies and services ranging from discovery (NCE and antibodies), over CRO/CMO activities and marketing & sales assignments. The collaboration will bring a better European coverage through combining networks and will also bring additional expertise in Marketing, Sales & Business Development towards our European Biotech & Pharma customers.

    News: 

Meet Dr Hagens and Dr Ridolphi during their participations to  EuroPLX Istanbul 9-10 June 08.

© RidePharmConsulting